Malaga Cove Capital, LLC Bausch Health Companies Inc. Transaction History

Malaga Cove Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$18.89 - $31.89 $614,189 - $1.04 Million	-32,514 Closed	0 $0
Q3 2019 Oct 31, 2019	SELL	$20.88 - $25.66 $9,959 - $12,239	-477 Reduced 1.45%	32,514 $710,000
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $16,621 - $21,424	-810 Reduced 2.4%	32,991 $832,000
Q1 2019 Apr 11, 2019	SELL	$20.23 - $26.29 $20,735 - $26,947	-1,025 Reduced 2.94%	33,801 $835,000
Q4 2018 Feb 04, 2019	SELL	$17.64 - $28.32 $11,413 - $18,323	-647 Reduced 1.82%	34,826 $646,000
Q3 2018 Oct 15, 2018	BUY	$20.64 - $25.67 $732,162 - $910,591	35,473 New	35,473 $954,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Malaga Cove Capital, LLC with notifications on news.